VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 27, 2013) - Bearclaw Capital Corp. (News - Market indicators)(FRANKFURT:5BQ) announces that it granted options to two directors pursuant to its stock option plan on July 23, 2013. An option to acquire 150,000 common shares was granted to each of Arthur Lilly and Robert MacGillivray. Both of the options are for a five-year term which expires on July 22, 2018. For each grant, 30% vested immediately, 30% vests on the first anniversary of the grant and the remaining 40% vests on the second anniversary of the grant. The exercise price is $0.10 per common share.

The news release may contain forward-looking statements. Known and unknown risks and uncertainties may cause actual events or results to materially differ from those expressed or implied by any such forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the contents of this release.